Neo-Fs Index: A Novel Immunohistochemical Biomarker Panel Predicts Survival and Response to Anti-Angiogenetic Agents in Clear Cell Renal Cell Carcinoma

SIMPLE SUMMARY: Although anti-angiogenetic agents (AAA) are mainstay treatments for clear cell renal cell carcinoma (ccRCC), there are very few histology-based predictive biomarkers applicable in routine clinical practice. Considering that frameshifts contribute to antitumor immunity and ccRCC harbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jisup, Park, Jee-Young, Shin, Su-Jin, Lim, Beom Jin, Go, Heounjeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000111/
https://www.ncbi.nlm.nih.gov/pubmed/33801954
http://dx.doi.org/10.3390/cancers13061199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000111/
https://www.ncbi.nlm.nih.gov/pubmed/33801954
http://dx.doi.org/10.3390/cancers13061199

Ejemplares similares